Formosa Pharmaceuticals, Inc.

Formosa Pharmaceuticals, Inc. is a dynamic biopharmaceutical company dedicated to innovation and excellence in pharmaceutical manufacturing. With a focus on ophthalmology and oncology, Formosa Pharmaceuticals is committed to developing and delivering advanced therapeutic solutions. The company's flagship asset, APP13007, has been approved by the US FDA, marking a significant milestone in their dedication to advancing patient care.

Located at Primary: 8F-6 No. 57 Fuxing North Road, Songshan District, Taipei City 105, TW, Formosa Pharmaceuticals leverages cutting-edge technology and a dedicated team of professionals to drive growth and expand its portfolio. The acquisition of Activus Pharma and its Activus Pure Nanoparticle Technology (APNT) Platform further solidifies Formosa Pharmaceuticals' position as a leader in the industry, enhancing its capabilities in nanoparticle technology for improved drug delivery.

Formosa Pharmaceuticals is poised for continued success and expansion in the pharmaceutical sector. The company's strategic vision and commitment to innovation ensure that Formosa Pharmaceuticals remains at the forefront of developing solutions for unmet medical needs. We invite the manager of Formosa Pharmaceuticals, Inc. to create a customized and exclusive company showcase and product listing on our platform to further enhance your market presence and connect with potential partners and customers.